The trial that scared a generation of women off hormone therapy has been substantially reinterpreted, and when you start it appears to change the risk-benefit. If you are within about ten years of menopause or under sixty with bothersome symptoms, this is a conversation worth reopening with a knowledgeable clinician.
The 2002 Women's Health Initiative reported higher risks with hormone therapy and drove a sharp drop in its use. What the headlines skipped is that the average participant was in her sixties, many years past menopause, which is not the same woman as one starting treatment at fifty-one.
You cannot lift your way out of a five hour night
Same people, same deficit, two sleep conditions. The body gave up something different each time.
If you are eating for protein and training for lean mass, sleep is the third variable in that equation.
Researchers at the University of Chicago ran a crossover trial. The same participants spent fourteen days with 8.5 hours in bed, then fourteen days with 5.5, on an identical calorie deficit both times.
On the longer sleep they lost 1.4 kilograms of fat. On the shorter sleep they lost 0.6.
Fat free mass went the other direction. They lost 1.5 kilograms of it on the longer sleep and 2.4 on the shorter.
In the restricted condition, roughly a quarter of the weight they lost was fat. The rest came out of the tissue you are working to keep.
Be clear about the limits. Ten participants, three of them women, average age 41, so this is not a study of women over fifty and should not be read as one.
What makes it worth your attention is the direction. A body of research on the menopause transition, including the SWAN cohort, finds sleep getting shorter and more broken through those years, which is exactly when lean mass is hardest to hold.
So defend the window before you add another gram of protein. Yu Sleep is two droppers taken thirty minutes before bed, at the same time every night.
The melatonin dose is 0.9 milligrams, where a standard drugstore bottle runs 5 or 10. That is the one number worth reading on any sleep label.
Take your deep sleep average this week first. That is what you will judge it against in eight weeks, and the 60 day guarantee covers that whole window.
Later analyses by age told a different story. Women who began therapy in their fifties or within ten years of menopause showed a more favorable profile, and in that group some analyses pointed to lower coronary risk and mortality rather than harm.
A randomized trial called ELITE tested this directly. Estrogen started early, within six years of menopause, slowed the progression of early artery thickening, while the same treatment started ten or more years out did not, which is the core of the timing hypothesis.
Set apart from the debate, some things are settled. Hormone therapy is the most effective treatment for hot flashes and night sweats according to major menopause guidelines, and it helps protect bone and reduce fractures.
The risks are real and specific, not a reason for blanket fear. Combined estrogen and progestogen carries a small increase in breast cancer risk that grows with duration, and oral estrogen raises the risk of blood clots, while patches and gels absorbed through the skin appear to carry less clot risk.
This is an individual decision, not a group one. It is not right for everyone, including women with a history of breast cancer, blood clots, stroke, or certain other conditions, which is exactly why it belongs in a real evaluation rather than a headline.
So bring specifics to your doctor. Ask whether you are a candidate given your history, ask about transdermal estradiol as a route, and ask how symptoms, bone health, and your personal risks weigh out for you.
The move is not to start hormones, it is to stop letting a misread headline decide for you. If you are near menopause and struggling, get an individualized answer while the timing window is open.
